Abstract:MAES, MICHAEL, SIMON SCHARPE, EUGENE BOSMANS, MAURITS VANDEWOUDE, EDUARD SUY, WIM UYTTENBROECK, WALTER COOREMAN, CARINE VANDERVORST and JEF RAUS Disturbances in Acute Phase Plasma Proteins during Melancholia Additional Evidence for an Inflammatory Process during that Illness. Prog. Neuro-Psychopharmacol & Biol Psychiat 1992,16(4)501–515. 1. Leukocyte enumeration through flow cytometry has revealed that severe depression may be accompanied by a systemic immune activation, indicative of an Inflammatory response The latter condition allegedly involves an important modification of acute phase plasma protein (APP) equilibrium 2. In order to elucidate whether the state of severe depression is represented by alterations in APPs, the authors measured: α, antitrypsin (α1,AT), α2, macroglobulln (α2,M), haptoglobin (Hp), α, acid glycoprotein (α1,S), transferrin (Tf), complement component 4 (C4) and C-reactive protein (CRP). Interleukin-1-β (II-1B) and lnterleukin-6 (II-6) circulating levels were determined 3. Hyperhaptoglobinemia and hypotransferinemia are hallmarks for major depression and depression per se, respectively, The disorders in Hp and Tf circulating levels are highly sensitive to (83%) and specific for (100%) melancholia as opposed to the healthy state. 4. Disorders in both APPs are significantly related to the absolute number of blood monocytes. 5. The authors observed a trend towards lower α2M and higher α,S values in severely depressed subjects. Severity of depression was significantly related to Hp and α1S (both positively) and to α2M and Tf (both negatively) values. 6. No significant intercategory differences in C4 could be established, whilst only a few subjects exhibited measurable CRP, II-1β and II-6 circulating levels. 7. Our findings may support the hypothesis that depression Is accompanied by an inflammatory response

Lower Total Serum Protein, Albumin, and Beta- and Gamma-Globulin in Major and Treatment-Resistant Depression: Effects of Antidepressant Treatments

Total Serum-Protein and Serum-Protein Fractions in Depression - Relationships to Depressive Symptoms and Glucocorticoid Activity

Lower Serum L-Tryptophan Availability in Depression As a Marker of a More Generalized Disorder in Protein Metabolism

Higher Alpha-1-Antitrypsin, Haptoglobin, Ceruloplasmin and Lower Retinol Binding-Protein Plasma-Levels During Depression - Further Evidence for the Existence of an Inflammatory Response During That Illness

Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression.

Immune Disturbances in Treatment‐Resistant Depression: Modulation by Antidepressive Treatments

Lower Serum Dipeptidyl Peptidase IV Activity in Treatment Resistant Major Depression: Relationships with Immune-Inflammatory Markers.

Serum Levels of Excitatory Amino Acids, Serine, Glycine, Histidine, Threonine, Taurine, Alanine and Arginine in Treatment‐resistant Depression: Modulation by Treatment with Antidepressants and Prediction of Clinical Responsivity

Lower Serum Zinc in Major Depression is a Sensitive Marker of Treatment Resistance and of the Immune/inflammatory Response in That Illness.

Serotonin-immune Interactions in Major Depression: Lower Serum Tryptophan As a Marker of an Immune-Inflammatory Response

Anthropometric and Biochemical Assessment of the Nutritional State in Depression: Evidence for Lower Visceral Protein Plasma Levels in Depression

Reduced Number of Red Blood Cells, Lowered Hematocrit and Hemoglobin, and Increased Number of Reticulocytes in Major Depression As Indicators of Activation of the Inflammatory Response System: Effects of Antidepressant Drugs

Alterations in Iron Metabolism and the Erythron in Major Depression: Further Evidence for a Chronic Inflammatory Process.

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.

Lower Serum Zinc in Major Depression in Relation to Changes in Serum Acute Phase Proteins.

Increased Neopterin and Interferon-Gamma Secretion and Lower Availability of L-tryptophan in Major Depression: Further Evidence for an Immune Response

Disturbances in Acute Phase Plasma Proteins During Melancholia: Additional Evidence for the Presence of an Inflammatory Process During That Illness

The acute phase response in depression: A review

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Lower Serum Vitamin E Concentrations in Major Depression. Another Marker of Lowered Antioxidant Defenses in That Illness.

Relationships Between Lower Plasma L-tryptophan Levels and Immune-Inflammatory Variables in Depression